Evidence map›Paper›PMID 41394922›Full record

ArticleFrontiers in physiology2025

Sympathetic vasomotion as an early marker of hemorrhage.

Peter Ricci Pellegrino, Alicia M Schiller, Iraklis I Pipinos, Irving H Zucker, Han-Jun Wang

Abstract read
In one paragraph

Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Peter Ricci PellegrinoDepartment of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States.
Alicia M SchillerDepartment of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States.
Iraklis I PipinosDepartment of Surgery, University of Nebraska Medical Center, Omaha, NE, United States.
Irving H ZuckerDepartment of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, United States.
Han-Jun WangDepartment of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States.

Funding

MitoQ treatment of claudication: myofiber and micro-vessel pathologyR01AG077803 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Iraklis Ilias Pipinos · 2022 to 2026
$3.0M
Nrf2 regulation of oxidative stress in heart failure and extra vesicular communicationR01HL153176 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI TIAN, CHANGHAI, ZUCKER, IRVING H · 2021 to 2024
$2.6M
Neural Inflammation and Exercise Pressor Reflex in Heart FailureR01HL169205 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HANJUN WANG · 2023 to 2026
$2.5M
Stellate Ganglia Nrf2 Signaling and Enhanced Cardiac Sympathetic Tone in Chronic Heart FailureR01HL172029 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HANJUN WANG, Irving H Zucker · 2024 to 2026
$2.2M
Novel Neural Mechanisms underlying Lung-Heart Pathological CrosstalkR01HL152160 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WANG, HANJUN · 2020 to 2023
$2.2M
Nrf2 and the exaggerated Exercise Pressor Reflex in Peripheral Arterial DiseaseR01HL171602 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HANJUN WANG · 2024 to 2026
$1.9M
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart FailureR21HL170127 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DUAN, BIN, WANG, HANJUN · 2023 to 2024
$422k
NHLBI NIH HHS R01 HL152160NHLBI NIH HHS R01 HL153176NHLBI NIH HHS R01 HL169205NHLBI NIH HHS R01 HL171602NHLBI NIH HHS R01 HL172029NHLBI NIH HHS R21 HL170127NIA NIH HHS R01 AG077803RRD VA I21 RX004632
6 · The paper itself

Abstract

Introduction: Each year, over 1.8 million people die from hemorrhagic shock, and, since the median time from onset to death is only two hours, early recognition is the cornerstone of management. The sympathetic nervous system is the fastest physiological hemodynamic compensatory mechanism, and we have developed a novel measure of sympathetic vascular control called sympathetic vasomotion which could serve as an early marker of hemorrhage. Methods: We performed unilateral renal denervation on six rabbits and instrumented these rabbits with bilateral renal flow probes and arterial pressure telemeters to allow for measurement of sympathetic vasomotion in paired vascular beds that differed only by sympathetic innervation. After a two-week recovery period, conscious rabbits then underwent controlled blood withdrawal via an auricular arterial catheter to simulate hemorrhage. Results: Vasomotion differences between innervated and denervated kidneys in admittance gain, phase shift, and coherence increased significantly prior to increases in heart rate or decreases in blood pressure. Discussion: These data suggest that sympathetic vasomotion could be a useful physiologically based biomarker for the early detection of hemorrhage. Further studies are needed to evaluate the utility of monitoring the sympathetic nervous system in clinical settings.

Indexed as

autonomic denervationbiomarkerblood pressurehemorrhagehomeostasisrenal circulationsignal processing, digitalsympathetic nervous system

Identifiers

PMID41394922
PMCPMC12695573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.